Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection.
D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008297:Male; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications; D011471:Prostatic Neoplasms / Q000150:complications; D011804:Quinolines / Q000627:therapeutic use; D001744:Urinary Bladder Calculi / Q000150:complications; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D011804:Quinolines; D009268:Nalidixic Acid